Interim report January-June 2017: Investments for the future and fewer working days puts pressure on the result for the period
· Divestment of weak businesses in Århus and Helsinki will strengthen the results in coming periods but has a negative one-time effect of SEK -16.3 million on the quarter · Considerably fewer working days impact the clinics’ results negatively · Successful start-up of GHP Vård och Hälsa with Trygg Hansa and development of the collaboration with Skandia · Much greater focus on internal cost control in the clinics in future Second quarter 2017 · Sales revenues decreased to SEK 249.6 million (262.0) · Organic growth amounted to -4.5 percent (22.1) · Adjusted EBITDA